New Drugs Approved by the FDA; New Dosage Forms and Indications Approved by the FDA; Agents Pending FDA Approval; New Drug or Biologics License Applications Filed by Manufacturer; Supplemental Applications Filed by Manufacturer; Significant Labeling Changes or “Dear Health Care Professional” Letters Related to Safety
-
Published:2009-04
Issue:4
Volume:44
Page:340-344
-
ISSN:0018-5787
-
Container-title:Hospital Pharmacy
-
language:en
-
Short-container-title:Hosp Pharm
Affiliation:
1. Drug Information Center, College of Pharmacy, Washington State University Spokane, PO Box 1495, Spokane, WA 99210-1495.
Abstract
This monthly feature will help readers keep current on new drugs, new indications, dosage forms, and safety-related changes in labeling or use. Efforts have been made to ensure the accuracy of this information; however, if there are any questions, please let us know at hospitalpharmacy@drugfacts.com .
Publisher
SAGE Publications
Subject
Pharmacology (medical),Pharmacology,Pharmacy
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pegloticase for chronic gout;Cochrane Database of Systematic Reviews;2010-03-17